The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading lower by 30 points at 22,629, indicating that the domestic benchmark indices are likely to make a muted start on Thursday. 

Earlier on Wednesday, 30 September, the domestic benchmark indices S&P BSE Sensex slumped by 48.78 points or 0.07%, and settled at 72,480 while the Nifty50 traded 0.42% lower, closing at 22,620.

Here are some stocks that are likely to remain in focus on 1 October.

Aurobindo Pharma: Aurobindo Pharma’s biopharmaceutical subsidiary, Acrotech Biopharma Inc., has launched ADQUEY (difamilast 1%) ointment in the US. The non-steroidal topical treatment is indicated for mild-to-moderate atopic dermatitis in adults and children aged two years and above.

NCC: NCC has secured two additional orders in September with a combined value of Rs 500.22 crore. Of the total, orders worth Rs 224.74 crore are from the buildings division, while Rs 275.48 crore comes from the transportation division.

Symbiotec Pharma: Knovea Pharmaceutical, a wholly owned subsidiary of Symbiotec Pharmalab, has signed a definitive agreement with a leading global pharmaceutical company. The deal grants the partner exclusive rights to commercialise and distribute two dual-chamber vial-based injectable products in the US.

Highway Infrastructure: Highway Infrastructure has entered into an agreement with the Uttar Pradesh Expressways Industrial Development Authority for a Rs 220.66-crore work order involving user fee collection and toll plaza operations on the Gorakhpur Link Expressway. The company has also received a Rs 24.46-crore Letter of Acceptance from the National Highways Authority of India for operations at Velanchettiyur Fee Plaza in Tamil Nadu.

Lemon Tree Hotels: Lemon Tree Hotels has opened Keys Prima by Lemon Tree Hotels in Darjeeling, marking the group’s first hotel in the town and strengthening its presence in West Bengal. The 65-room property is managed by Carnation Hotels, a subsidiary of Lemon Tree Hotels.

Infosys: Infosys and ABN AMRO Bank have expanded their strategic partnership to support the bank’s AI-led transformation. Under the expanded collaboration, Infosys will provide application development, testing and support services to modernise ABN AMRO’s IT systems, improve operational efficiency and enhance scalability. 

Tired of missing hot stocks? Tradz by EquityPandit provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!